SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-125867
Filing Date
2021-10-13
Accepted
2021-10-13 17:14:07
Documents
8
Period of Report
2021-10-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2129111d3_8k.htm 8-K 29073
2 EXHIBIT 1.1 tm2129111d3_ex1-1.htm EX-1.1 276593
3 EXHIBIT 4.1 tm2129111d3_ex4-1.htm EX-4.1 65334
4 EXHIBIT 5.1 tm2129111d3_ex5-1.htm EX-5.1 15741
5 EXHIBIT 10.1 tm2129111d3_ex10-1.htm EX-10.1 41702
6 EXHIBIT 99.1 tm2129111d3_ex99-1.htm EX-99.1 10102
7 EXHIBIT 99.2 tm2129111d3_ex99-2.htm EX-99.2 10197
8 GRAPHIC tm2129111d3_ex5-1img001.jpg GRAPHIC 7334
  Complete submission text file 0001104659-21-125867.txt   460313
Mailing Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065
Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065 650-847-1919
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 211321877
SIC: 2834 Pharmaceutical Preparations